Marc Martinell is the founder of Minoryx Therapeutics. Minoryx Therapeutics has raised $138M in total funding. Latest round: Series C.
Marc Martinell is the Co-founder and CEO of Minoryx Therapeutics, a biotechnology company founded in 2011. The company focuses on developing treatments for life-threatening rare neurometabolic diseases, specifically pharmacological chaperones for genetic diseases affecting the central nervous system. He has overseen clinical trials for adult ALD patients and Rett syndrome.
Full founder directory · Investor directory · Company funding database · Fundraising library